Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

The ALK Inhibitor Ceritinib Overcomes Crizotinib Resistance in Non–Small Cell Lung Cancer

PaperCitations, authors & open-access status

The ALK Inhibitor Ceritinib Overcomes Crizotinib Resistance in Non–Small Cell Lung Cancer is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 847 citations, 2014 year and bronze oa status.

847
Citations
2014
Year
bronze
OA Status

Related on ScholarIQ

Alice T. Shaw
Author
Justin F. Gainor
Author
Jeffrey A. Engelman
Author
Cancer Discovery
Journal
Lung Cancer Treatments and Mutations
Topic
Lung Cancer Treatments and Mutations
Topic
470M+ articles · free account